• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunotherapy-induced interstitial lung disease: Cases report.

作者信息

Abbas Waseem, Rao Ranga Raju, Gupta Vineet Govinda, Popli Swati

机构信息

Department of Medical Oncology, Max Institute of Cancer Care, New Delhi, India.

Max-Super Speciality Hospital Shalimarbagh, New Delhi, India.

出版信息

South Asian J Cancer. 2019 Apr-Jun;8(2):79. doi: 10.4103/sajc.sajc_23_19.

DOI:10.4103/sajc.sajc_23_19
PMID:31069182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6498714/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee25/6498714/bfb2a44a713e/SAJC-8-79-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee25/6498714/ce5c862aa4cf/SAJC-8-79-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee25/6498714/bfb2a44a713e/SAJC-8-79-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee25/6498714/ce5c862aa4cf/SAJC-8-79-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee25/6498714/bfb2a44a713e/SAJC-8-79-g002.jpg

相似文献

1
Immunotherapy-induced interstitial lung disease: Cases report.免疫疗法诱发的间质性肺病：病例报告
South Asian J Cancer. 2019 Apr-Jun;8(2):79. doi: 10.4103/sajc.sajc_23_19.
2
Fibrotic lung toxicity induced by cytotoxic drugs, radiation and immunotherapy in patients treated for lung cancer.细胞毒性药物、放疗及免疫疗法在肺癌治疗患者中引发的肺纤维化毒性。
Monaldi Arch Chest Dis. 2018 Jun 21;88(2):917. doi: 10.4081/monaldi.2018.917.
3
A Rare Combination of Dermatomyositis, Interstitial Pneumonia, and Lung Cancer in a Patient Treated with Immunosuppressive Therapy and Chemotherapy.一名接受免疫抑制治疗和化疗的患者出现皮肌炎、间质性肺炎和肺癌的罕见组合。
Intern Med. 2018 Mar 15;57(6):849-853. doi: 10.2169/internalmedicine.9642-17. Epub 2017 Dec 8.
4
Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.FOLFOX治疗相关间质性肺炎的预后与治疗：呼吁对呼吸功能不全患者采用多模式免疫调节治疗
BMC Cancer. 2017 Aug 29;17(1):586. doi: 10.1186/s12885-017-3576-y.
5
[Can nivolumab be used safely in idiopathic pulmonary fibrosis?].[纳武单抗能否安全用于特发性肺纤维化？]
Rev Mal Respir. 2019 Feb;36(2):209-213. doi: 10.1016/j.rmr.2018.11.001. Epub 2019 Jan 24.
6
Anti-PD-1-Related Exacerbation of Interstitial Lung Disease in a Patient with Non-Small Cell Lung Cancer: A Case Presentation and Review of the Literature.抗 PD-1 相关非小细胞肺癌患者间质性肺病恶化：病例报告及文献复习。
Cancer Invest. 2020 Jul;38(6):365-371. doi: 10.1080/07357907.2020.1783677. Epub 2020 Jul 2.
7
Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.肝动脉内注射5-氟尿嘧啶联合皮下注射α-干扰素治疗晚期肝细胞癌所致间质性肺炎
J Gastroenterol. 2004 Aug;39(8):793-7. doi: 10.1007/s00535-004-1375-0.
8
[Drug-induced interstitial pneumonitis due to avelumab: A case report].[阿维鲁单抗所致药物性间质性肺炎：一例报告]
Rev Mal Respir. 2018 Nov;35(9):978-982. doi: 10.1016/j.rmr.2018.07.005. Epub 2018 Oct 11.
9
Respiratory failure due to infliximab induced interstitial lung disease.因英夫利昔单抗导致的间质性肺病引起的呼吸衰竭。
Heart Lung. 2013 Nov-Dec;42(6):480-2. doi: 10.1016/j.hrtlng.2013.07.005. Epub 2013 Aug 19.
10
Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.FOLFOX + FOLFIRI与亚叶酸钙联合贝伐单抗治疗后发生的间质性肺疾病：一例报告
J Oncol Pharm Pract. 2018 Oct;24(7):540-543. doi: 10.1177/1078155217718616. Epub 2017 Jul 11.

本文引用的文献

1
Anti PD-1 immunotherapy related interstitial lung disease presenting as respiratory failure - A review with case series.以呼吸衰竭为表现的抗程序性死亡蛋白1免疫治疗相关间质性肺疾病——病例系列综述
Respir Med Case Rep. 2018 Nov 12;26:17-22. doi: 10.1016/j.rmcr.2018.11.005. eCollection 2019.
2
Immunotherapy-induced pneumonitis: cases report.免疫疗法诱发的肺炎：病例报告。
Einstein (Sao Paulo). 2018 Jun 21;16(2):eRC4030. doi: 10.1590/S1679-45082018RC4030.
3
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
免疫检查点抑制剂与癌症患者的间质性肺病相关。
Eur Respir J. 2017 Aug 10;50(2). doi: 10.1183/13993003.00050-2017. Print 2017 Aug.
4
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis.检查点抑制剂相关肺炎的临床特征、诊断挑战及管理策略
Cancer Manag Res. 2017 Jun 14;9:207-213. doi: 10.2147/CMAR.S136818. eCollection 2017.
5
Pembrolizumab-induced pneumonitis.帕博利珠单抗诱发的肺炎。
ERJ Open Res. 2017 May 2;3(2). doi: 10.1183/23120541.00081-2016. eCollection 2017 Apr.
6
Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.程序性细胞死亡蛋白 1 抑制剂相关肺炎在晚期癌症患者中的发生率：系统评价和荟萃分析。
JAMA Oncol. 2016 Dec 1;2(12):1607-1616. doi: 10.1001/jamaoncol.2016.2453.
7
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.美国胸科学会/欧洲呼吸学会官方声明：特发性间质性肺炎的国际多学科分类的更新。
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48. doi: 10.1164/rccm.201308-1483ST.
8
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.
9
The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis.吸烟状态对晚期非小细胞肺癌患者行为及生存结局的影响：一项回顾性分析。
Chest. 2004 Dec;126(6):1750-6. doi: 10.1378/chest.126.6.1750.
10
Inflammation and cancer.炎症与癌症。
Nature. 2002;420(6917):860-7. doi: 10.1038/nature01322.